At present, there are only four studies investigating the clinical associations between CXCL16 polymorphisms and atherosclerosis (Wang et al., 2010; Zivković et al., 2015), coronary heart disease (Petit et al., 2011) and multiple sclerosis (Stojković et al., 2014). This evidence concerns the gene CXCL16 and multiple sclerosis.